OOIR: Observatory of International Research

Papers

(The H4-Index of International Clinical Psychopharmacology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	39
The role of personality traits in following quarantine orders during the COVID-19 pandemic	33
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	19
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	18
Clinical specificity profile for novel rapid acting antidepressant drugs	16
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	15
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	15
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	14
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	14
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	14
Antidepressant psychopharmacology: is inflammation a future target?	13
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	12
Managing depression in the elderly: real-world clinical considerations and perspectives	12
Open issues in bipolar and antipsychotic treatments	12
Case series on aripiprazole and dopamine supersensitivity psychosis	12